检索

期
标题
作者
编号 16 (2012)
Khronicheskaya serdechnaya nedostatochnost' u bol'nykh sakharnym diabetom: sovremennye predstavleniya
Ettinger O.
PDF
(Rus)
编号 16 (2012)
Nevropatiya i prediabet: eti chasy nachinayut tikat' rano
Ametov A., Lysenko M.
PDF
(Rus)
编号 7 (2012)
PAINFUL DIABETIC POLYNEUROPATHY
Strokov I., Strokov I.
编号 3 (2012)
HOW TO EFFECTIVELY MANAGE TWO MAJOR DEFECTS IN TYPE 2 DIABETES MELLITUS?
Biryukova E., Antsiferov M., Biryukova Y., Antsiferov M.
编号 16 (2011)
Hypoglycaemia in pregnant women with type 1 diabetes mellitus
Arbatskaya N., Tisel'ko A., Ignatova N., Arbatskaya N., Tiselko A., Ignatova N.
编号 16 (2011)
APPROACHES TO THE TREATMENT OF DIABETES MELLITUS IN ELDERLY PATIENTS: POTENTIALS FOR USE OF INSULIN NOVOMIX 30
Surkova E., Surkova E.
编号 3 (2011)
PATHOGENETIC ASPECTS OF TREATMENT OF DISTAL PERIPHERAL POLYNEUROPATHY IN PATIENTS WITH DIABETES MELLITUS
Begma A., Begma I., Begma A., Begma I.
编号 16 (2010)
ASSESSMENT OF EFFICACY OF EDUCATION OF GENERAL PRACTITIONERS BY THE TRAINING PROGRAM FOR MANAGEMENT OF TYPE 2 DIABETES MELLITUS
Yu Mayorov A., Surkova Y., Dedov I., Mayorov A., Surkova E., Dedov I.
编号 16 (2010)
ETIOPTHOGENIC ROLE OF INSULIN RESISTANCE IN THE DEVELOPMENT OF METABOLIC AND VASCULAR DISORDERS IN TYPE 2 DIABETES MELLITUS
Demidova T., Demidova T.
编号 3 (2010)
New possibilities for type 2 diabetes mellitus therapy. Results of a pilot observation program of efficacy and safety of the drug «Galvus» (vildagliptin) therapy in Moscow and in the regions of the Russian Federation
Pavlova M., Pavlova M.
编号 20 (2009)
Primenenie bazal'no-bolyusnogo rezhima insulinoterapii u bol'nykh sakharnym diabetom tipa 2
Antsiferov M., Morgunov L.
编号 17 (2009)
INNOVATsIONNYY KOMBINIROVANNYY PREPARAT GALVUS MET (VILDAGLIPTIN + METFORMIN) V LEChENII SAKhARNOGO DIABETA TIPA 2
Antsiferov M.
编号 8 (2009)
Bisoprolol in therapy of arterial hypertension and ischemic heart disease
Kirichenko A., Kirichenko A.
编号 3 (2009)
Experience of incritinomimetic exenatide (Byetta) use in the treatment of patients with type 2 diabetes mellitus with obesity
Antsiferov M., Koteshkova O., Sitnikov V., Mityaeva O., Pashintseva L., Budantseva T., Ivanova E., Anciferov M., Koteshkova O., Sitnikov V., Mityaeva O., Pashinceva L., Budanceva T., Ivanova E.
卷 29, 编号 11/12 (2022)
Three-phase course of central diabetes insipidus in a child after removal of craniopharyngioma: a clinical case
Strebkova N., Kalinin A.
PDF
(Rus)
卷 29, 编号 6 (2022)
Obesity as a factor in the development of gestational diabetes mellitus
Osmanova S., Tsakhilova S., Tsarkova M., Saschenko A.
PDF
(Rus)
卷 28, 编号 12 (2021)
Time is more precious than gold. Choosing a strategy for the successful management of a patient with suspected LADA-diabetes (clinical case)
Smirnova E.
PDF
(Rus)
卷 28, 编号 12 (2021)
Insulin resistance - a common enemy for endocrinologists and cardiologists
Verbovoy A., Dolgikh Y.
PDF
(Rus)
卷 28, 编号 4 (2021)
The use of collagen plates in orthopedic dental rehabilitation of patients with drug-compensated diabetes mellitus
Shevkunova N., Vorobyov M., Gushchin V.
PDF
(Rus)
卷 27, 编号 12 (2020)
Resolution on the results of the expert panel «IDegLira: is it 1 + 1 or anything more?»
Antsiferov M., Galstyan G.
PDF
(Rus)
卷 27, 编号 12 (2020)
Clinical features of skin lesions in patients with diabetes mellitus
Svechnikova E., Lykova S., Nemchaninova O., Morzhanaeva M.
PDF
(Rus)
卷 27, 编号 4 (2020)
The role of vitamin D in preventing pregnancy complications in gestational diabetes mellitus
Kyazimova A., Abdullaeva R., Polukhova S., Babaeva S.
PDF
(Rus)
卷 26, 编号 4 (2019)
Extreme risk category in the stratification of cardiovascular complications. Consensus Council of experts
Expert C.
PDF
(Rus)
卷 26, 编号 4 (2019)
Experience of the use of insulin degludec in the treatment of patients with type 1 diabetes mellitus (according to the data of the Moscow segment of the Federal Diabetes Register)
Demidov N., Mishra O., Antsiferov M.
PDF
(Rus)
编号 11 (2018)
Adiponectin and metabolic parameters in patients with type 2 diabetes mellitus and hypothyroidism
Verbovoy A., Lomonova T., Sharonova L.
PDF
(Rus)
编号 4 (2018)
ASSESSMENT OF THE EFFICACY AND SAFETY OF INSULIN DEGLUDEC IN CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES MELLITUS IN REAL-LIFE CLINICAL PRACTICE
Kiyaev A., Kondrashova O., Chernykh L., Pollyak O., Yusupova A., Slovak M., Zaykova I.
PDF
(Rus)
编号 16 (2017)
Effect of SGLT-2 inhibitors on cardiovascular outcomes: review of results of CVD-REAL trial
Antsiferov M.
PDF
(Rus)
编号 6 (2017)
THE USE OF ANTIBACTERIAL DRUGS DURING ORTHOPAEDIC ALIGNMENT WITH REMOVABLE LAMINAR DENTURES IN PATIENTS WITH TYPE 2 DIABETES MELLITUS TAKING INTO ACCOUNT THE RESULTS OF PCR-BASED DIAGNOSTICS
Shevkunova N.
PDF
(Rus)
编号 5 (2017)
SAFE AND EFFECTIVE COMBINATION OF ULTRALONG-ACTING BASAL INSULIN DEGLUDEC AND ULTRA-SHORT ACTING INSULINE ASPART IN CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES MELLITUS
Girsh Y., Veliyeva O.
PDF
(Rus)
编号 16 (2016)
Current approaches to therapy of type 2 diabetes mellitus in the era of new data on cardiovascular safety
Antsiferov M., Schernthaner G.
PDF
(Rus)
编号 5 (2016)
DIABETIC ANGIOPATHY «PAINFUL» POINTS: FOCUS ON HYPERTRIGLYCERIDEMIA AND FENOFIBRATE POTENTIAL
Rujatkina L., Rujatkin D., Zemljanuhina S.
PDF
(Rus)
编号 17 (2015)
10 let ispol'zovaniya pompovoy insulinoterapii v moskovskoy pediatricheskoy praktike -
Rybkina I., Petryaykina E., Koltunov I.
PDF
(Rus)
编号 5 (2015)
Effektivnost' trekhkomponentnoy terapii s ispol'zovaniem liraglutida (Viktoza) -pervogo analoga glyukagonopodobnogo peptida-1 dlitel'nogo deystviya - u patsientov s sakharnym diabetom 2 tipa i vistseral'nym ozhireniem
Antsiferov M., Koteshkova O.
PDF
(Rus)
编号 18 (2014)
Primenenie Aktovegina kak universal'nyy metod lecheniya oslozhneniy sakharnogo diabeta
Meleshkevich T., Luchina E., Lukashova M.
PDF
(Rus)
编号 16 (2014)
Fiksirovannaya kombinatsiya saksagliptina i metformina modifitsirovannogo vysvobozhdeniya - novyy shag v uluchshenii priverzhennosti k lecheniyu sakharnogo diabeta 2 tipa
Biryukova E.
PDF
(Rus)
编号 5 (2014)
KLINIKA, DIAGNOSTIKA I LEChENIE DIABETIChESKOY NEYROPATII
Sharonova L., Verbovoy A., Sharonova D.
PDF
(Rus)
编号 16 (2013)
Osnovnye printsipy lecheniya nesakharnogo diabeta u detey
Strebkova N.
PDF
(Rus)
编号 16 (2013)
Novyy klass antidiabeticheskikh preparatov - ingibitory natriy-glyukoznykh kotransporterov
Ushkalova E.
PDF
(Rus)
编号 5 (2013)
PREIMUShchESTVA METFORMINA PROLONGIROVANNOGO DEYSTVIYa
Petunina N., Trukhina L., Sinitsyna E., Antsiferov M.
PDF
(Rus)
编号 5 (2013)
REGIDRATATsIONNAYa TERAPIYa I VOZMOZhNOSTI EE KONTROLYa U PATsIENTOV S DIABETIChESKIMI KOMAMI (OBZOR LITERATURY)
Legun A., Vetsheva M.
PDF
(Rus)
编号 16 (2012)
Mnogofaktornoe upravlenie sakharnym diabetom 2 tipa: kakovy nashi segodnyashnie vozmozhnosti
Galstyan G.
PDF
(Rus)
编号 11 (2012)
Osobennosti lecheniya narusheniy tolerantnosti k glyukoze u patsientov s abdominal'no-vistseral'nym tipom ozhireniya na rannikh etapakh ego razvitiya
Shilov A., Abdullaeva A.
PDF
(Rus)
编号 7 (2012)
DIPEPTIDYL PEPTIDASE-4 INHIBITORS IN COMBINATION WITH METFORMIN: EXPERIENCE OF USE OF GALVUS MET IN REAL-LIFE CLINICAL PRACTICE IN MOSCOW
Antsiferov M., Antsiferov M.
编号 3 (2012)
SULFONYLUREAS IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS TODAY. IS THERE A PROSPECT?
Kononenko I., Smirnova O., Smirnova O., Kononenko I.
编号 16 (2011)
DIABETES INSIPIDUS IN CHILDREN
Strebkova N., Pisareva E., Strebkova N., Pisaryova E.
编号 16 (2011)
SAXAGLIPTIN (ONGLYZA ®) IN CONCEPTION OF EFFECTIVE MANAGEMENT OF TYPE 2 DIABETES MELLITUS
Petunina N., Brashchenkova A., Petunina N., Brashcenkova A.
编号 3 (2011)
CLINICAL ASPECTS FOR USE OF DIPEPTIDYL PEPTIDASE-4 INHIBITORS IN COMBINATION WITH METFORMIN: BENEFITS FOR DIFFERENT GROUPS OF PATIENTS
Antsiferov M., Antsiferov M.
编号 16 (2010)
POSSIBILITY OF CORRECTION OF OXIDATIVE STRESS IN PATIENTS WITH DIABETES USING DIBICOR
Zanozina O., Zanozina O.
编号 16 (2010)
POTENTIALS FOR USE OF DIPEPTIDYL PEPTIDASE-4 INHIBITORS IN TYPE 2 DIABETES MELLITUS: INITIATION AND CONTINUATION OF THERAPY
Antsiferov M., Zilov A., Antsiferov M., Zilov A.
编号 3 (2010)
Innovative approaches to the treatment of type 2 diabetes mellitus: the role of specialized product for enteral nutrition "Glucerna SR"
Sharafetdinov K., Plotnikova O., Sharafetdinov K., Plotnikova O.
编号 20 (2009)
Polinevropatii v terapevticheskoy praktike
Erofeeva S.
编号 17 (2009)
DIABETIChESKAYa PERIFERIChESKAYa POLINEVROPATIYa: SOVREMENNYE PREDSTAVLENIYa O PATOGENEZE I PODKhODY K TERAPII
Komelyagina E., Antsiferov M.
编号 3 (2009)
The effectiveness of the drug Vessel Due F in patients with diabetes with nonproliferative and preproliferative diabetic retinopathy
Ishchenko I., Milen'kaya T., Ischenko I., Milenkaya T.
编号 3 (2009)
Prospects of the first human glucagon-like peptide 1 analog liraglutid use in the treatment of patients with type 2 diabetes mellitus
Antsiferov M., Dorofeeva L., Anciferov M., Dorofeeva L.
301 - 354 的 354 信息 << < 1 2 3 4 

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回（例如，隐含AND）
  • 使用OR结合多个检索词，便于查找含有这些检索词的文章，例如education OR research
  • 使用括号来创建更复杂的查询; 例如：archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如： "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如：online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语
##common.cookie##